Advancing clinical-grade tumor-infiltrating lymphocyte therapy manufacturing
Oct
24
2023
On demand

Advancing clinical-grade tumor-infiltrating lymphocyte therapy manufacturing

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Advancing clinical-grade tumor-infiltrating lymphocyte therapy manufacturing

The field of adoptive cell therapy for solid malignancies have made groundbreaking strides using tumor-infiltrating lymphocytes (TILs). Despite the progress, there are still hurdles to overcome in TIL manufacturing. The journey to success lies in refining manufacturing protocols for a brighter clinical outlook.

Join this webinar and discover innovative cell manufacturing solutions. Learn how to generate tumor-reactive T cells (TRTs) for TIL therapy, all within a standardized and seamlessly automated framework.

Attend this webinar to learn about:

  • How to master closed system automation for the efficient production of TIL cell products
  • Solutions tailored to your clinical-scale TIL manufacturing needs
  • GMP-compliant cell sorting for specific tumor-reactive T cell subsets in a closed system


Arina Riabinska
Arina Riabinska
R&D Team Coordinator, Personalized Immunotherapy at Miltenyi Biotec
Arina’s journey began with a master's in medical neurosciences, at the Charité, Berlin. A PhD in genetics followed at the University of Cologne, alongside two years as a postdoctoral researcher, where she explored T cell based immune surveillance. In her current role as an R&D team coordinator at Miltenyi Biotec she works on process development of personalized immunotherapies focusing on tumor-infiltrating lymphocytes (TILs) and tumor-reactive T cells (TRTs).

SPEAKERS

Arina Riabinska
Arina Riabinska
R&D Team Coordinator, Personalized Immunotherapy at Miltenyi Biotec

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual
27 June
in 57
Days
Register
Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products

Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products

Ryan Massopust
11 June
in 41
Days
Register
Precision in production: optimizing monitoring and quality control for high-value plasmids

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko
6 June
in 36
Days
Register
Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Advancing cell therapy: innovations in polymer-based encapsulation and delivery

Y Brudno, O Veiseh, M Delic-Schlumbohm et al.
5 June
in 35
Days
Register
Creating a closed-process, semi-automated workflow for human MSC expansion, harvest, and final fill

Creating a closed-process, semi-automated workflow for human MSC expansion, harvest, and final fill

Julien Muzard, Donnie Beers
30 May
in 29
Days
Register